4 reports of this reaction
2.2% of all ACETAMINOPHEN, PHENYLEPHRINE HCL reports
#6 most reported adverse reaction
ABDOMINAL PAIN UPPER is the #6 most commonly reported adverse reaction for ACETAMINOPHEN, PHENYLEPHRINE HCL, manufactured by Better Living Brands, LLC. There are 4 FDA adverse event reports linking ACETAMINOPHEN, PHENYLEPHRINE HCL to ABDOMINAL PAIN UPPER. This represents approximately 2.2% of all 184 adverse event reports for this drug.
Patients taking ACETAMINOPHEN, PHENYLEPHRINE HCL who experience abdominal pain upper should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ABDOMINAL PAIN UPPER is a less commonly reported adverse event for ACETAMINOPHEN, PHENYLEPHRINE HCL, but still significant enough to appear in the safety profile.
In addition to abdominal pain upper, the following adverse reactions have been reported for ACETAMINOPHEN, PHENYLEPHRINE HCL:
The following drugs have also been linked to abdominal pain upper in FDA adverse event reports:
ABDOMINAL PAIN UPPER has been reported as an adverse event in 4 FDA reports for ACETAMINOPHEN, PHENYLEPHRINE HCL. This does not prove causation, but indicates an association observed in post-market surveillance data.
ABDOMINAL PAIN UPPER accounts for approximately 2.2% of all adverse event reports for ACETAMINOPHEN, PHENYLEPHRINE HCL, making it a notable side effect.
If you experience abdominal pain upper while taking ACETAMINOPHEN, PHENYLEPHRINE HCL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.